Heart Failure 2026, together with World Congress of Acute Heart Failure, organised by the Heart Failure Association of ESC, takes place May 9 – May 12, 2026 in Barcelona, Spain.
The conference provides breakthrough therapies, novel devices and digital health solutions and we are going to present the concept of Relaxin-2 therapy in HFpEF at the hub of “Future Frontiers in Heart Failure”.
Thomas Bernd Dschietzig is going to attend and present – feel free to connect with us for an on-site meeting.